

> 


# CALCIUM DISORDERS

![](https://i.imgur.com/YMLaq30.jpg)

Pitfalls in measuring calcium

• Physiologically active Ca is free or ionized (ICa). Serum Ca reflects total calcium (bound + unbound) and ∴ influenced by albumin (main Ca-binding protein).

• Corrected Ca (mg/dL) = measured Ca (mg/dL) + {0.8 × \[4 – albumin (g/dL)\]}

• Alkalosis will cause more Ca to be bound to albumin (∴ total Ca may be normal but ↓ ICa)

• Best to measure **ionized Ca directly** _(but accuracy is lab dependent)_

HYPERCALCEMIA

<table><colgroup><col> <col></colgroup><tbody><tr><td colspan="2"><p><b>原因 of Hypercalcemia</b></p></td></tr><tr><td><p><b>Category</b></p></td><td><p><b>原因</b></p></td></tr><tr><td><p><b>Hyperparathyroidism</b> (<b>HPT</b>)</p><p><span>(</span><span><i>NEJM</i></span> <span>20</span><span>1</span><span>8;379:</span><span>1</span><span>05;</span> <span><i>Lancet</i></span> <span>20</span><span>1</span><span>8;39</span><span>1</span><span>:</span><span>1</span><span>68)</span></p></td><td><p><b>1</b>°: <b>adenoma</b> (85%), hyperplasia (15–20%; spont. vs. MEN1/2A), carcinoma (&lt;1%), meds (Lithium → ↑ PTH)</p><p><b>3</b>°: after long-standing 2° hyperparathyroidism (as in renal failure) → autonomous nodule develops, requires surgery</p></td></tr><tr><td><p><b>Familial hypocalciuric hypercalcemia</b> (<b>FHH</b>)</p></td><td><p>Inact. mut. in Ca-sensing receptor (FHH1), Gα11 (FHH2), AP2S1 (FHH3) → ↑ Ca set point; ± mild ↑ PTH</p><p>Acquired form due to autoAb vs. Ca-sensing receptor (rare)</p><p>FE<sub>Ca</sub> [(24-h U<sub>Ca</sub>/serum Ca) / (24-h U<sub>Cr</sub>/serum Cr)] &lt;0.01</p></td></tr><tr><td><p><b>Malignancy</b></p><p><span>(</span><span><i>JCEM</i></span> <span>20</span><span>1</span><span>5;</span><span>1</span><span>00:2024)</span></p></td><td><p>PTH-related peptide (PTHrP) → humoral ↑ Ca of malignancy (eg, squamous cell cancers, renal, breast, bladder)</p><p>Cytokines → ↑ osteoclast activity (eg, hematologic malig)</p><p>↑ 1,25-(OH)<sub>2</sub>D (eg, rare lymphomas)</p><p>Local osteolysis (eg, breast cancer, myeloma)</p></td></tr><tr><td><p><b>Vitamin D excess</b></p></td><td><p>Granulomas (sarcoid, TB, histo, GPA) → ↑ 1-OHase → ↑ 1,25-(OH)<sub>2</sub>D. Vitamin D intoxication.</p></td></tr><tr><td><p>↑ <b>Bone turnover</b></p></td><td><p>Hyperthyroidism, immobilization + Paget’s disease, vitamin A</p></td></tr><tr><td><p><b>Miscellaneous</b></p></td><td><p>Thiazides; Ca-based antacids or massive dairy consumption (milk-alkali syndrome); adrenal insufficiency</p></td></tr><tr><td colspan="2"><p><i>Among inPts with hypercalcemia: 45% have cancer, 25% 1° HPT, 10% CKD</i> → <i>3</i>° <i>HPT</i></p></td></tr></tbody></table>

(_JCEM_ 2005;90:6316; _NEJM_ 2013;368:644)

臨床表現 (“bones, stones, abdominal groans, and psychic moans”)

• **Hypercalcemic crisis** (usually when Ca >13–15): polyuria, dehydration, ΔMS

Ca toxic to renal tubules → blocks ADH activity, causes vasoconstriction and ↓ GFR → polyuria but Ca reabsorption → ↑ serum Ca → ↑ nephrotoxicity and CNS sx

• Osteopenia, fractures, and osteitis fibrosa cystica (latter seen in severe hyperpara. only →

↑ osteoclast activity → cysts, fibrous nodules, salt & pepper appearance on X-ray)

• Nephrolithiasis, nephrocalcinosis, nephrogenic DI

• Abdominal pain, anorexia, nausea, vomiting, constipation, pancreatitis, PUD

• Fatigue, weakness, depression, confusion, coma, ↓ DTRs, short QT interval

• 1° HPT: 80% asx, 20% nephrolithiasis, osteoporosis, etc.

Diagnostic studies

• Hyperparathyroidism (HPT) and malignancy account for 90% of cases of ↑ Ca; HPT more likely if asx or chronic; malignancy (usually overt) more likely if acute or sx

• Ca, alb, ICa, PTH (may be inapprop. normal in 1° HPT & FHH; _JAMA_ 2014;312:2680), PO4;

↑ or high 正常 PTH: 24-h UCa >200 mg → HPT; 24-h UCa <100 mg & FECa <0.01 → FHH

↓ PTH: ✔ PTHrP, Aϕ, & search for malig (eg, CT, mammogram, SPEP/UPEP) and ✔ vit D: ↑ 25-(OH)D → meds; ↑ 1,25-(OH)2D → granuloma (✔ CXR, ACE, 排除 lymph)

![](https://i.imgur.com/0AelVUR.jpg)

(_BMJ_ 2015;350:h2723)

治療 of asymptomatic 1° HPT (_JCEM_ 2014;99:3561)

• Surgery if: age <50 y; serum Ca >1 mg/dL >ULN; CrCl <60 mL/min, DEXA T score <–2.5

• If surgery declined/deferred, can Rx with cinacalcet (↓ Ca & PTH but may not ↑ BMD)

• If not yet candidate for surgery: ✔ serum Ca & Cr annually and BMD q2y

Calciphylaxis (calcific uremic arteriolopathy)

• Calcification of media of small- to med-sized blood vessels of dermis & SC fat

• Ischemia & skin necrosis. See “Chronic Kidney Disease” for further details.

HYPOCALCEMIA

<table><colgroup><col> <col></colgroup><tbody><tr><td colspan="2"><p><b>原因 of Hypocalcemia</b></p></td></tr><tr><td><p><b>Category</b></p></td><td><p><b>原因</b></p></td></tr><tr><td><p><b>Hypoparathyroidism</b> <span>(</span><span><i>NEJM</i></span> <span>20</span><span>1</span><span>9;380:</span><span>1</span><span>738)</span></p></td><td><p>Iatrogenic (s/p thyroidectomy, rarely after parathyroidectomy); sporadic; familial (APS1, activating Ca-sensing receptor mutations; see <a href="text/part0012_split_000.html#page_7-2">page 7-2</a>); Wilson’s, hemochromatosis; hypoMg (↓ secretion and effect); activating Ca-sensing receptor autoAb</p></td></tr><tr><td><p><b>Pseudo- hypoparathyroidism</b></p><p><span>(</span><span><i>JCEM</i></span> <span>20</span><span>11</span><span>;96:3020)</span></p></td><td><p>Ia and Ib: PTH end-organ resistance (∴ ↑ serum PTH) Ia: + skeletal abnormalities, short stature, &amp; retardation Pseudopseudohypoparathyroidism = Ia syndrome but <i>nl</i> Ca &amp; PTH</p></td></tr><tr><td><p><b>Vit D defic. or resist</b> <span>(</span><span><i>NEJM</i></span> <span>20</span><span>11</span><span>;364:248;</span> <span><i>JCEM</i></span> <span>20</span><span>1</span><span>2;97:</span><span>11</span><span>53)</span></p></td><td><p>Nutritional/sunlight deprivation; GI disease/fat malabs.; drugs (anticonvulsants, rifampin, ketoconazole, 5-FU/leucovorin); genetic (1α-hydroxylase, VDR mutations)</p></td></tr><tr><td><p><b>Chronic renal failure</b></p></td><td><p>↓ 1,25-(OH)<sub>2</sub>D production, ↑ PO<sub>4</sub> from ↓ clearance</p></td></tr><tr><td><p><b>Accelerated net bone formation</b></p></td><td><p>Postparathyroidectomy, Paget’s disease <span>(</span><span><i>NEJM</i></span> <span>20</span><span>1</span><span>3;368:644)</span>, osteoblastic metastases</p></td></tr><tr><td><p><b>Calcium sequestration</b></p></td><td><p>Pancreatitis, citrate excess (after blood transfusions), acute ↑↑ PO<sub>4</sub> (ARF, rhabdomyolysis, tumor lysis), bisphosphonates</p></td></tr></tbody></table>

臨床表現

• **Neuromuscular irritability:** perioral paresthesias, cramps, ⊕ **Trousseau’s** (inflation of BP cuff ≥3 min → carpal spasm), ⊕ **Chvostek’s** (tapping facial nerve → contraction of facial muscles), laryngospasm; irritability, depression, psychosis, seizures, ↑ QT

• Rickets and/or osteomalacia: chronic ↓ vit D → ↓ Ca, ↓ PO4 → ↓ bone/cartilage mineralization, growth failure, bone pain, muscle weakness

• **Renal osteodystrophy** (↓ vit D & ↑ PTH in renal failure): osteomalacia \[↓ mineralization of bone due to ↓ Ca and 1,25-(OH)2D\] & osteitis fibrosa cystica (due to ↑ PTH)

Diagnostic studies

• Ca, alb, ICa, PTH, 25-(OH)D, 1,25-(OH)2D (if renal failure or rickets), Cr, Mg, PO4, Aϕ, UCa

治療 (also treat concomitant vitamin D deficiency)

• Severely symptomatic: Ca gluconate (1–2 g IV over 20 min) + oral Ca + calcitriol (but takes hrs to work) ± Mg (50–100 mEq/d); 10% CaCl2 in codes or via CVL

• Consider Ca gtt or PO to follow b/c effect of IV bolus typically lasts only a few hours

• Chronic (depends on etiol.): oral Ca (1–3 g/d; citrate better absorbed than carbonate, esp. if achlorhydria or on PPI) and typically calcitriol (0.25–2 mcg/d), and replete vit. D defic. Consider thiazide to ↓ urinary Ca or recombinant PTH 1-84 (if hypopara).

• Chronic renal failure: phosphate binder(s), oral Ca, calcitriol or analogue
